Navigation Links
TEI Biosciences Launches SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction
Date:10/17/2007

BOSTON, Oct. 17 /PRNewswire/ -- TEI Biosciences Inc. announces the launch of its SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction product. TEI has received 510(k) clearance from the U.S. Food and Drug Administration to market SurgiMend for expanded use in plastic and reconstructive surgery, including breast reconstruction, and for tendon augmentation, in addition to the previously cleared hernia repair and muscle flap reinforcement indications.

"SurgiMend has been the biologic material of choice for many general, plastic, and trauma surgeons for their hernia repair and muscle flap reinforcement needs. With multiple indications, excellent handling and suturing characteristics, and a rapid hydration rate that saves valuable operating room time, SurgiMend has the potential to become the medical community's primary choice for soft tissue repair and reconstruction. In addition, SurgiMend provides an opportunity for hospitals to cover a broad range of applications with a single biologic device at a single price point," said Yiannis Monovoukas, Ph.D., TEI's Chairman, President, and CEO.

SurgiMend is an acellular, terminally sterilized biologic matrix derived from the dermis of fetal calves, one of the purest sources of collagen available. It is intrinsically strong yet soft and pliable when hydrated, and handles like natural tissue; it readily conforms to the surgical site and is easily sutured. SurgiMend is rich in Type III collagen, the active collagen found in developing and healing tissues. It is not artificially crosslinked and its biochemistry and microporosity facilitate rapid cell penetration, revascularization, and integration with host tissues. SurgiMend is available in multiple sizes, both large and small, and can be stored dry at room temperature for up to three years.

SurgiMend will be on display at the American Society of Plastic Surgeons meeting in Baltimore, MD, October 29-30, at booth # 145.

About TEI Biosciences<
'/>"/>

SOURCE TEI Biosciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2010)... , ... Offers Online Promotions – Discounts on Stereomicroscopy and Converting to 3D Imaging , ... Thornwood, N.Y. (PRWEB) March ... a variety of research, clinical and industrial applications, recently announced two exciting online promotions. ...
(Date:3/17/2010)... ... leading provider of next generation business intelligence software, today announced the availability of Centrifuge ... , ... March 17, 2010 -- Centrifuge Systems, Inc. , a leading provider of next ...
(Date:3/16/2010)... , TAMPA, Fla. (March 16, 2010)Approximately half of Americans ... some point during the course of their disease. Radiofrequency ... in the tumor causing cancer cell death with minimal ... prolongation of their life by nearly three years, note ...
(Date:3/16/2010)... Fe, NM, USA -- March 12, 2010A Materials Design client ... of the General Motors R&D Center, has been honored with ... , Fundamentals of Interfacial Tribology, Multi-scale Modeling of High-temperature Deformation ... honor of John M. Campbell, a former scientific director of ...
Breaking Biology Technology:Carl Zeiss Offers Online Promotions 2Centrifuge Releases New Data Visualization Software 2Centrifuge Releases New Data Visualization Software 3Living longer: Colon cancer patients gain time with radiofrequency ablation treatment 2Living longer: Colon cancer patients gain time with radiofrequency ablation treatment 3
... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical ... McMahon, Ph.D.,chairman and CEO, will present at the 11th ... 10, at 10 a.m. Eastern Time at the,Waldorf-Astoria in ... will provide a corporate overview, including a discussion of,the ...
... Shares of Common StockAt a Price of $5.00 per ... Group, Inc. (the "Company" or "PharmaNet") (Nasdaq: ... today announced that it has signed a definitive merger ... ("JLL"). Under the terms of the Merger Agreement, JLL ...
... Corporation,(Nasdaq: DNDN ) today announced that management will ... Investor Conference in New York City, on,Tuesday, February 10, 2009 ... live audio webcast of the presentation will be accessible through ... you are unable to listen to the live webcast, it ...
Other Biology Technology:Poniard Pharmaceuticals to Present at the BIO CEO & Investor Conference 2PharmaNet Development Group Agrees to be Acquired by JLL Partners 2PharmaNet Development Group Agrees to be Acquired by JLL Partners 3PharmaNet Development Group Agrees to be Acquired by JLL Partners 4PharmaNet Development Group Agrees to be Acquired by JLL Partners 5PharmaNet Development Group Agrees to be Acquired by JLL Partners 6PharmaNet Development Group Agrees to be Acquired by JLL Partners 7
(Date:3/17/2010)... press conferences will take place during the March Meeting of ... 2010 in the Portland Convention Center. Journalists are invited to ... found at the end of this release. , MONDAY ... (session B2) , This briefing highlights one of the most ...
(Date:3/17/2010)... Tourists wanting to watch and swim with dolphins are now ... protect both the animals and the local communities whose livelihoods ... off the coast of Zanzibar has found that the many ... preventing them from resting, feeding and nurturing their young. , ...
(Date:3/17/2010)... of Chicago scientists have successfully used geometrically patterned surfaces ... approach is a departure from that of many stem-cell ... proteins in controlling the fate of stem cells. , ... both cases it,s the shape alone that,s dictating whether ...
Breaking Biology News(10 mins):Physics press conferences at next week's American Physical Society March Meeting 2Physics press conferences at next week's American Physical Society March Meeting 3Physics press conferences at next week's American Physical Society March Meeting 4Physics press conferences at next week's American Physical Society March Meeting 5Physics press conferences at next week's American Physical Society March Meeting 6Physics press conferences at next week's American Physical Society March Meeting 7Physics press conferences at next week's American Physical Society March Meeting 8Physics press conferences at next week's American Physical Society March Meeting 9Physics press conferences at next week's American Physical Society March Meeting 10Physics press conferences at next week's American Physical Society March Meeting 11Physics press conferences at next week's American Physical Society March Meeting 12Thrill-seeking holiday-makers are putting dolphins at risk 2Encorium Re Appoints Dr Kai Lindevall as Chief Executive Officer and Appoints Current Director Shahab Fatheazam Chairman of the Board 7367 1Encorium Re Appoints Dr Kai Lindevall as Chief Executive Officer and Appoints Current Director Shahab Fatheazam Chairman of the Board 7367 2Encorium Re Appoints Dr Kai Lindevall as Chief Executive Officer and Appoints Current Director Shahab Fatheazam Chairman of the Board 7367 3Encorium Re Appoints Dr Kai Lindevall as Chief Executive Officer and Appoints Current Director Shahab Fatheazam Chairman of the Board 7367 4Encorium Re Appoints Dr Kai Lindevall as Chief Executive Officer and Appoints Current Director Shahab Fatheazam Chairman of the Board 7367 5Encorium Re Appoints Dr Kai Lindevall as Chief Executive Officer and Appoints Current Director Shahab Fatheazam Chairman of the Board 7367 6Insulated Transport Containers Go Green 64546 1Insulated Transport Containers Go Green 64546 2QualiSystems TestShell now Maximizes Test Lab Resource Management 7364 1QualiSystems TestShell now Maximizes Test Lab Resource Management 7364 2QualiSystems TestShell now Maximizes Test Lab Resource Management 7364 3
... As part of the ongoing mission to train and ... in genomics, the J. Craig Venter Institute,s (JCVI) Eukaryotic ... TX March 3rd-5th to train 40 United States Agriculture ... , The training session will focus on the use ...
... University of Pennsylvania team has completed the first successful ... blood flow in patients with acute stroke, a leading ... of this research is to improve the management of ... continuous bedside monitoring of brain blood flow and metabolism. ...
... country will convene on the University of Houston for a ... issues and intervention strategies. , The UH Texas ... 10 at the UH M.D. Anderson Library, Rockwell Pavilion. ... and have high hopes that others will see the wealth ...
Other Biology News:JCVI program trains USDA scientists on eukaryotic genome analysis 2Penn research team tests bedside monitoring of brain blood flow and metabolism in stroke victims 2Texas Obesity Research Center at UH assembles researchers to discuss obesity 2
Conjugate Quality Control Evaluation Specificity: Conjugate Quality Control Evaluation ...
Qa-1 (L-12)...
... This Kit Contains the following: , Coated ... plate sealers , Wash/Sample Diluent: 300 mL of ... 1 vial 10 microg lyophilized peptide , Lyophilized ... microL of 50X concentrate , Secondary Antibody-HRP: 30 ...
Peptide Sequence: ovine COX-1 amino acids 272-282 (LMHYPRGIPPQ) To be used in conjunction with Cayman's COX-1 (ovine) polyclonal antiserum (Catalog No. 160108) to block protein-antibody complex f...
Biology Products: